Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
2,949.00    -78.00 (-2.58%)
Bid:
2,942.00
Ask:
2,946.00
Spread: 4.00 (0.136%)
Market Cap: £4.11b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Board Appointment

6 Feb 2012 14:00

RNS Number : 8693W
Croda International PLC
06 February 2012
 



6 February 2012

 

Croda International Plc

 

Appointment of Chief Technology Officer

Croda International Plc, the speciality chemicals company, is pleased to announce that Keith Layden has been appointed to the Board as an executive director with immediate effect, in the new role of Chief Technology Officer.

Keith joined Croda in 1984 and for the past 7 years has been President of our Enterprise Technology and Actives businesses, where he has overseen significant growth in innovation and expansion into new product areas. Prior to this he held a number of Managing Director roles across our European business. As Chief Technology Officer, Keith will be responsible for accelerating the identification, development, licensing and acquisition of innovative technologies, the global co-ordination of Croda's R&D activities and the development of novel production processes for our major existing core product platforms.

Steve Foots, Croda's Chief Executive, commented,

"Keith's appointment to the Board is recognition of the importance the capture of external technologies is to our short and medium term growth plans. This is an exciting new role for Keith and the organisation."

Martin Flower, Croda's Chairman, commented,

 "We are delighted that Keith has joined the Croda Board in this important new role. His wealth of experience of the chemical industry and its related technologies will be of great value during the next phase of Croda's development. "

 

There are no further matters to be disclosed under LR9.6.13R of the Listing Rules of the UK Listing Authority.

Enquiries:

Ben Foster, Pendomer Communications

020 3603 5221

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABXGDDCBGBGDL
Date   Source Headline
4th Aug 20258:46 amRNSDirector/PDMR Shareholding
1st Aug 20253:43 pmRNSDirector/PDMR Shareholding
1st Aug 20251:31 pmRNSDirector/PDMR Shareholding
31st Jul 20253:42 pmRNSDirector/PDMR Shareholding
29th Jul 20252:33 pmRNSDirector/PDMR Shareholding
29th Jul 20252:31 pmRNSDirector/PDMR Shareholding
29th Jul 20257:00 amRNSResults for the six months ended 30 June 2025
16th Jul 20252:08 pmRNSDirector/PDMR Shareholding
12th Jun 202510:01 amRNSDirector/PDMR Shareholding
6th Jun 20258:45 amRNSCorporate Broker Appointment
2nd Jun 20258:44 amRNSDirector/PDMR Shareholding
29th May 20258:57 amRNSDirector/PDMR Shareholding
13th May 20253:48 pmRNSDirector/PDMR Shareholding
6th May 20252:26 pmRNSDirector/PDMR Shareholding
24th Apr 202511:40 amRNSResult of AGM
23rd Apr 20257:00 amRNSFirst quarter 2025 sales update
11th Apr 20252:33 pmRNSDirector/PDMR Shareholding
11th Apr 20252:06 pmRNSDirector/PDMR Shareholding
7th Apr 202511:14 amRNSDirector/PDMR Shareholding
4th Apr 20253:49 pmRNSDirector/PDMR Shareholding
3rd Apr 20253:47 pmRNSDirector/PDMR Shareholding
31st Mar 202512:14 pmRNSDirector/PDMR Shareholding
27th Mar 20259:57 amRNSDirector Declaration
25th Mar 202512:30 pmRNSDirector/PDMR Shareholding
25th Mar 202512:27 pmRNSDirector/PDMR Shareholding
25th Mar 202512:26 pmRNSDirector/PDMR Shareholding
25th Mar 202512:23 pmRNSDirector/PDMR Shareholding
25th Mar 202512:21 pmRNSDirector/PDMR Shareholding
25th Mar 202512:21 pmRNSDirector/PDMR Shareholding
25th Mar 202512:17 pmRNSDirector/PDMR Shareholding
25th Mar 202512:14 pmRNSDirector/PDMR Shareholding
13th Mar 202512:38 pmRNSAnnual Financial Report
11th Mar 20252:54 pmRNSDirector/PDMR Shareholding
11th Mar 20257:13 amRNSDirector Declaration
10th Mar 202510:42 amRNSHolding(s) in Company
3rd Mar 20253:49 pmRNSDirectorate Change
25th Feb 202511:30 amRNSDirector/PDMR Shareholding
25th Feb 20257:00 amRNSFinal Results
11th Feb 20253:12 pmRNSDirector/PDMR Shareholding
13th Jan 20252:19 pmRNSDirector/PDMR Shareholding
11th Dec 20243:09 pmRNSDirector/PDMR Shareholding
11th Dec 20241:54 pmRNSDirector/PDMR Shareholding
9th Dec 20242:36 pmRNSHolding(s) in Company
29th Nov 202412:12 pmRNSHolding(s) in Company
20th Nov 20241:42 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSDirectorate Change
12th Nov 20242:47 pmRNSDirector/PDMR Shareholding
11th Nov 20247:00 amRNSThird quarter 2024 sales update
1st Nov 20241:44 pmRNSHolding(s) in Company
11th Oct 20242:13 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.